Consainsights logo
Reports / Overactive Bladder Treatment Market

Overactive Bladder Treatment Market

Overactive Bladder Treatment Market Research Report – Segmented By Pharmacotherapy (Anticholinergics, Botox, Intravesical Instillation, Mirabegron, Neurostimulation), Disease (Idiopathic Overactive Bladder, Neurogenic Overactive Bladder) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Overactive Bladder Treatment Market from Consainsights analyses the Overactive Bladder Treatment Market in the Life Sciences industry over the forecast period to 2026.

Overactive Bladder Treatment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Overactive Bladder Treatment segmentation includes Pharmacotherapy, Disease and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Pharmacotherapy, the Overactive Bladder Treatment Market analysis covers Anticholinergics, Botox, Intravesical Instillation, Mirabegron, Neurostimulation.

Based on the Disease, the Overactive Bladder Treatment Market analysis covers Idiopathic Overactive Bladder, Neurogenic Overactive Bladder.

Key companies operating in the market include Astellas Pharma Inc., Pfizer, Inc., Teva Pharmaceutical Industries Limited, Allergan, Plc., Mylan N.V., Endo International Plc, Hisamitsu Pharmaceutical Co., Inc., Sanofi, Aurobindo Pharma Limited, Johnson & Johnson, Intas Pharmaceuticals Ltd., Apotex Inc., Macleods Pharmaceuticals Ltd., Medtronic Plc, Cogentix Medical, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Pharmacotherapy (2019)
    Revenue Share (%), By Pharmacotherapy (2019)
  • Revenue Share (%), By Disease (2019)
    Revenue Share (%), By Disease (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Pharmacotherapy

By Pharmacotherapy, The Global Overactive Bladder Treatment Market analysis covers Anticholinergics, Botox, Intravesical Instillation, Mirabegron, Neurostimulation.

Global Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (Us$ Mn), By Pharmacotherapy, 2019-2027
Global Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (Us$ Mn), By Pharmacotherapy, 2019-2027

The Anticholinergics segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Anticholinergics: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Anticholinergics: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)

The Botox segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Botox: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Botox: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)

The Intravesical Instillation segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Intravesical Instillation: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Intravesical Instillation: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)

The Mirabegron segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Mirabegron: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Mirabegron: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)

The Neurostimulation segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Neurostimulation: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Neurostimulation: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
04

By Disease

By Disease, The Global Overactive Bladder Treatment Market analysis covers Idiopathic Overactive Bladder, Neurogenic Overactive Bladder.

Global Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (Us$ Mn), By Disease, 2019-2027
Global Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (Us$ Mn), By Disease, 2019-2027

The Idiopathic Overactive Bladder segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Idiopathic Overactive Bladder: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Idiopathic Overactive Bladder: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)

The Neurogenic Overactive Bladder segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Neurogenic Overactive Bladder: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
Neurogenic Overactive Bladder: Global Overactive Bladder Treatment Market Revenue Opportunity (Us$ Mn)
05

North America

Based on the North America, the Overactive Bladder Treatment Market analysis covers United States, Canada.

North America Map
North America Overactive Bladder Treatment Market Size, 2019-2027 (Us$ Mn)
North America Overactive Bladder Treatment Size, 2019-2027 (Us$ Mn)
North America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
North America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
North America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
North America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
United States Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
United States Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
United States Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
United States Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Canada Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Canada Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Canada Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Canada Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
06

Europe

Based on the Europe, the Overactive Bladder Treatment Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Overactive Bladder Treatment Market Size, 2019-2027 (Us$ Mn)
Europe Overactive Bladder Treatment Size, 2019-2027 (Us$ Mn)
Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Germany Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Germany Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Germany Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Germany Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
United Kingdom Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
United Kingdom Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
United Kingdom Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
United Kingdom Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
France Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
France Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
France Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
France Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Spain Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Spain Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Spain Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Spain Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Russia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Russia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Russia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Russia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Italy Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Italy Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Italy Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Italy Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Europe Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
07

Asia-Pacific

Based on the Asia-Pacific, the Overactive Bladder Treatment Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Overactive Bladder Treatment Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Overactive Bladder Treatment Size, 2019-2027 (Us$ Mn)
Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
China Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
China Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
China Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
China Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Japan Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Japan Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Japan Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Japan Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
India Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
India Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
India Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
India Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Southeast Asia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Southeast Asia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Southeast Asia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Southeast Asia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Australia & New Zealand Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Australia & New Zealand Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Australia & New Zealand Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Australia & New Zealand Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Asia-Pacific Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Overactive Bladder Treatment Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Overactive Bladder Treatment Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Overactive Bladder Treatment Size, 2019-2027 (Us$ Mn)
Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Middle East Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Middle East Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Middle East Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Middle East Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Middle East & Africa Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
09

Latin America

Based on the Latin America, the Overactive Bladder Treatment Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Overactive Bladder Treatment Market Size, 2019-2027 (Us$ Mn)
Latin America Overactive Bladder Treatment Size, 2019-2027 (Us$ Mn)
Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Brazil Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Brazil Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Brazil Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Brazil Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Argentina Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Argentina Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Argentina Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Argentina Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Mexico Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Mexico Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Mexico Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Mexico Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Colombia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Colombia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Colombia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Colombia Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Pharmacotherapy, 2019-2027
Rest of Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
Rest of Latin America Overactive Bladder Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Disease, 2019-2027
10

Company Analysis

  • Astellas Pharma Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Limited
  • Allergan, Plc.
  • Mylan N.V.
  • Endo International Plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Sanofi
  • Aurobindo Pharma Limited
  • Johnson & Johnson
  • Intas Pharmaceuticals Ltd.
  • Apotex Inc.
  • Macleods Pharmaceuticals Ltd.
  • Medtronic Plc
  • Cogentix Medical, Inc.